AMAG PHARMACEUTICALS, INC.: cash_and_restricted_cash
| Value | {"amount": 138412000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2019-03-31) |
| Status | current |
| Entity | AMAG PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:01:04.991802+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b21a2c4b-5f3d-4449-8351-a94f0424cc31
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000792977-19-000084Retrieved: 2026-08-19T08:01:04.991802+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000792977/cash-and-restricted-cash/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b21a2c4b-5f3d-4449-8351-a94f0424cc31
History
- no predecessors — first report